Antipodes Partners awarded

2026 Fund Manager of the Year, Australia

Morningstar Awards 2026 © Morningstar, Inc. All Rights Reserved.

Antipodes Emerging Market Debt Fund

IMPORTANT INFORMATION
On Friday, 17 April 2026, unitholders of the Antipodes Emerging Markets Debt Fund were notified of a number of changes to the Fund that will take effect from Monday, 25 May 2026. For further details click here.

Fund overview

The Antipodes Emerging Market Debt Fund is an actively managed fixed income fund focused on identifying undervalued debt opportunities across emerging markets.

The Fund is managed using a disciplined, value-oriented approach supported by intensive, on-the-ground bottom-up fundamental research.

This process results in a concentrated portfolio of fixed interest securities issued by companies in emerging markets that, in the view of the Investment Manager, are undervalued, either on an absolute or relative basis, and have the potential to generate regular income as well as some capital appreciation.

Ratings

The Antipodes Emerging Market Debt Fund has been rated “Superior” by SQM Research.

Performance chart

Cumulative performance (over selected time horizon)

Antipodes Emerging Market Debt Fund

Returns greater than 1 year are annualised. Past performance is no indication of future performance. Calculations are based on exit price with distributions reinvested.

Net performance

wpDataTable with provided ID not found!
Returns greater than 1 year are annualised. Past performance is no indication of future performance. 1Inception is 31 August 2011.

The Fund was previously known as the Antipodes Asia Income Fund and Premium Asia Income Fund. Antipodes Partners Limited has appointed Value Partners under a sub-investment manager agreement to undertake portfolio management of the Fund. Value Partners have been the Investment Manager of this Fund since its inception.

Key facts

1The portfolio allocation ranges provided are indicative only. The Fund will be rebalanced within a reasonable period of time should the exposure move outside these ranges.

The publication of unit prices from 1st July 2025 onwards will be delayed while annual distribution amounts are finalised. The unit prices for 30th June 2025 are cum distribution and are reflective of fund performance to that date.

Unit price history
Distribution history
Portfolio profile as at 31st October 2026
Top 10 holdings (%)
Sector exposure (%)2
Portfolio characteristics and product composition (%)
Regional exposure (%)1, 3
1 Where possible, regions, countries and currencies classified on a look through basis. 2 GICS Classification. 3 Antipodes Partners classification.
Monthly updates
For historical reports, please contact the Antipodes team
For historical reports, please contact the Antipodes team
Invest

If you are applying using paper application forms, the minimum investment in the Antipodes Emerging Market Debt Fund is $25,000 for new investors and $10,000 for existing investors.


Who may invest in the fund

This fund is open to investors from Australia and New Zealand.


Important information

It is a legal requirement to download and read the Product Disclosure Statement before proceeding and we recommend that you consult a licensed financial advisor before making investment decisions.

Download Product Disclosure Statement (PDS).
Download Target Market Determination (TMD).


Apply online

The application below allows you to invest in the Antipodes Emerging Market Debt Fund.

If you are applying using paper application forms, the minimum investment in the Antipodes Emerging Market Debt Fund is $25,000 for new investors and $10,000 for existing investors.

Apply online


Apply via a paper form

Purchase, top-up or sell a managed fund investment the familiar way.

  1. Download an application form here
  2. Complete the application form & sign
  3. Provide certified copies of your identity to verify your identity
  4. Email service@pinnacleinvestment.com
 

Download an application form


Benefits of investing in the Antipodes Emerging Market Debt Fund

The Fund is an actively managed portfolio consisting of fixed interest securities issued by companies in Emerging Markets.

Benefits of investing in the Fund include:

  • Regular income and potential for long-term capital growth
  • Access to a prominent Hong Kong-based asset management company with a large and experienced investment team; and
  • Active management aimed at maximising potential for returns over the medium and longer-term.

Who is this fund for?

  • Investors seeking regular income with some long-term capital growth.
  • Those comfortable with medium-risk and return profile.
  • Investors looking to use the fund as a satellite to minor allocation in their portfolio with a 3–5 year investment horizon and who are unlikely to need to withdraw their money on less than one week’s notice.

Key fund information

Investment manager

Antipodes Partners Limited

Sub investment manager

Value Partners

Strategy

Emerging Markets Fixed Interest

Strategy inception date

August 2011

Investment objective

The Fund seeks current income and some capital appreciation by investing mostly in a diversified portfolio of high yielding, sub investment grade securities and non-rated securities across a range of emerging markets

Suggested minimum investment period

3 to 5 years

Minimum initial investment

A$25,000

Management fee

1.13% p.a. of the NAV of the Fund

 
Performance fee

Nil

Frequently asked questions

What is emerging market debt?

Emerging market debt refers to bonds and other fixed income securities issued by governments or companies in emerging economies. These securities allow investors to lend money to issuers in countries with developing economies in exchange for regular interest payments and potential capital appreciation.

Emerging market debt investing involves lending to governments or companies in emerging economies through bonds and other debt instruments. Investors earn returns through interest payments and potential capital gains if bond prices rise. Active managers assess factors such as credit quality, economic conditions, currency risks, and valuations to identify attractive opportunities while managing risks associated with political, economic, and market volatility.

There is no single “best” emerging market debt fund, as the right choice depends on an investor’s objectives, risk tolerance, and investment horizon. The Antipodes Emerging Market Debt Fund is a compelling option for investors seeking regular income, supported by an active investment approach focused on valuation discipline and managing downside risk across market cycles.

The Antipodes Emerging Market Debt Fund focuses on fixed income securities from emerging markets, aiming to provide regular income with potential for modest capital growth while managing risk across market cycles. In contrast, the Antipodes Emerging Markets Fund invests in equities of emerging market companies, targeting capital growth through a diversified portfolio of stocks. Because of these differences, the Debt Fund generally has lower volatility and more stable returns, while the Equity Fund is exposedto higher growth potential but greater market-driven risk.

Important information

This information has been prepared by Antipodes Partners Limited (‘Antipodes’) (ABN 29 602 042 035, AFSL 481 580) as the Investment manager of the Antipodes Emerging Market Debt Fund (ARSN 151 270 423 ) (‘Fund’). Maple-Brown Abbott Limited (“MBAL”) (ABN 73 001 208 564, AFSL 237296), is the Responsible Entity for the Antipodes Antipodes Emerging Market Debt Fund Fund. MBAL is a subsidiary of Antipodes Partners Holdings PTY LTD (ABN 91 602 828 526). 

This website contains general information only, and does not take into account your investment objectives, financial situation or specific needs. Before making any investment decision, you should seek independent financial advice. This document does not constitute an offer or solicitation by anyone in any jurisdiction. Past performance is not a reliable indicator of future performance. Neither MBA, nor any of its related parties, directors or employees, make any representation or give any guarantee as to the return of capital, performance, any specific rate of return, or the taxation consequences of, any investment.  

Any views expressed on individual stocks or other investments, or any forecasts or estimates, are not a recommendation to buy, sell or hold, they are point in time views and may be based on certain assumptions and qualifications not set out in part or in full in this document. Individual stocks  referred to  may or may not be currently held by the Fund. Information derived from sources is believed to be accurate, however such information has not been independently verified and may be subject to assumptions and qualifications not described in this document. To the extent permitted by law, neither MBA, nor any of its related parties, directors or employees, make any representation or warranty as to the accuracy, completeness, reasonableness or reliability of this information, or accept liability or responsibility for any losses, whether direct, indirect or consequential, relating to, or arising from, the use or reliance on this information.  Before making a decision whether to acquire, or to continue to hold an investment in the Fund, investors should obtain and consider the current PDS and Target Market Determination (TMD) or any other relevant disclosure document. For the Fund, the PDS, AIB and TMD are available at www.antipodes.com or by calling 1300 097 995. 

The rating contained on this page is issued by SQM Research Pty Ltd ABN 93 122 592 036AFSL 421913. SQM Research is an investment research firm that undertakes research on investment products exclusively for its wholesale clients, utilising a proprietary review and star rating system. The SQM Research star rating system is of a general nature and does not take into account the particular circumstances or needs of any specific person. The rating may be subject to change at any time. Only licensed financial advisers may use the SQM Research star rating system in determining whether an investment is appropriate to a person’s particular circumstances or needs. You should read the product disclosure statement and consult a licensed financial adviser before making an investment decision in relation to this investment product. SQM Research receives a fee from the Fund Manager for the research and rating of the managed investment scheme.

Now available on the ASX: the Antipodes Global SMID Active ETF (ASX:MIDS)

X